Aspect Biosystems, a biotechnology company pioneering microfluidic 3D bioprinting of human tissues, today announced a US $20 million Series-A financing round. Radical…
Aspect Biosystems, a biotechnology company pioneering microfluidic 3D bioprinting of human tissues, today announced a US $20 million Series-A financing round. Radical…